Welcome to BizHQ, a pharmaceutical information platform providing product specifications, packaging details, and international regulatory information.
Hexabol 76.5 mg/ml is labeled as an injectable preparation containing Trenbolone Hexahydrobenzylcarbonate, a synthetic anabolic-androgenic steroid.
The product packaging displays British Pharma branding and identifies the formulation as a 10 ml multidose vial intended for intramuscular administration.
Product Specifications
| Product Details | Information |
|---|---|
| Product Name | Hexabol |
| Generic Name | Trenbolone Hexahydrobenzylcarbonate |
| Strength | 76.5 mg/ml |
| Dosage Form | Injectable Solution |
| Packaging | 10 ml Multidose Vial |
| Brand Marking | British Pharma |
| Route on Label | Intramuscular |
| Category | Anabolic-Androgenic Steroid |
| Prescription Marking | Rx Only |
Specifications are based on the supplied product image and are not independently authenticated.
International Regulatory Information
Regulatory considerations for Hexabol and trenbolone compounds may be relevant to pharmaceutical professionals researching requirements in the following countries:
North America: United States, Canada, Mexico
Europe: United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Sweden, Norway, Denmark, Poland, Portugal, Ireland, Austria, Greece
Middle East: United Arab Emirates, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain
Asia: Japan, South Korea, Singapore, Malaysia, Thailand, Vietnam, Philippines, Indonesia
Oceania: Australia, New Zealand
Africa: South Africa, Kenya, Nigeria, Ghana, Tanzania, Uganda
South America: Brazil, Argentina, Chile, Colombia, Peru
These countries are included for informational and regulatory research purposes only. Their inclusion does not imply product approval, availability, or permission to import or distribute Hexabol.
Pharmaceutical Documentation and Compliance
Licensed pharmaceutical organizations assessing regulated medicines should verify the following documentation where applicable:
Manufacturer and product authenticity records
Certificate of Analysis (COA)
GMP documentation
Product registration or marketing authorization
Import and export permits
Controlled-substance licenses
Batch and expiry information
Importation and distribution must comply with the relevant laws of both the exporting and destination countries.
Safety and Regulatory Precautions
Trenbolone Hexahydrobenzylcarbonate is not FDA-approved for human medical use in the United States.
Potential health risks include cardiovascular complications, hormonal suppression, reproductive problems, and adverse psychological effects.
This product should not be promoted for bodybuilding, athletic performance enhancement, or unsupervised human use.
Frequently Asked Questions
Q1. What is Hexabol 76.5 mg/ml?
Hexabol is labeled as an injectable product containing Trenbolone Hexahydrobenzylcarbonate at 76.5 mg/ml.
Q2. What packaging is shown?
The supplied product image shows a 10 ml multidose vial.
Q3. Is Hexabol approved in every international market?
No. Approval cannot be assumed. Product registration and legal status must be verified separately in each country.
Q4. Can controlled anabolic steroids be internationally distributed?
Only where legally permitted and with all applicable pharmaceutical and controlled-substance authorizations.
Q5. What should pharmaceutical professionals verify before evaluating this product?
They should confirm the product's identity, authenticity, regulatory classification, approval status, and relevant manufacturer documentation.
Contact BizHQ
For pharmaceutical product information, regulatory enquiries, and general professional correspondence:
Company Name: BizHQ
Website: https://medicineindiaexport.com
WhatsApp / Contact: +91 9209725630
Location: India